- $864.64m
- $310.57m
- 41
- 31
- 58
- 39
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 26.6 | 49.4 | 89.7 | 102 | 152 |
Operating Profit | -26.6 | -49.4 | -89.7 | -102 | -152 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -57.2 | -49.6 | -90.3 | -102 | -138 |
Provision for Income Taxes | |||||
Net Income After Taxes | -57.4 | -49.5 | -90.1 | -102 | -142 |
Net Income Before Extraordinary Items | |||||
Net Income | -57.4 | -49.5 | -90.1 | -102 | -142 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -57.4 | -49.5 | -90.1 | -102 | -142 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -4.16 | -3.08 | -4.48 | -2.93 | -1.99 |